A detailed history of Group One Trading, L.P. transactions in Alector, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 2,000 shares of ALEC stock, worth $10,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Holding current value
$10,480
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $8,380 - $12,460
2,000 New
2,000 $9,000
Q3 2022

Nov 09, 2022

SELL
$8.19 - $13.2 $4,914 - $7,920
-600 Reduced 31.61%
1,298 $12,000
Q2 2022

Aug 11, 2022

SELL
$7.65 - $14.24 $459,765 - $855,824
-60,100 Reduced 96.94%
1,898 $19,000
Q1 2022

May 12, 2022

BUY
$13.02 - $20.78 $804,636 - $1.28 Million
61,800 Added 31212.12%
61,998 $883,000
Q4 2021

Feb 11, 2022

SELL
$19.35 - $25.54 $435,375 - $574,650
-22,500 Reduced 99.13%
198 $4,000
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $343,087 - $625,798
15,847 Added 231.31%
22,698 $518,000
Q2 2021

Aug 10, 2021

BUY
$15.5 - $22.48 $65,053 - $94,348
4,197 Added 158.14%
6,851 $143,000
Q1 2021

May 12, 2021

SELL
$14.84 - $22.23 $17,407 - $26,075
-1,173 Reduced 30.65%
2,654 $53,000
Q4 2020

Feb 10, 2021

BUY
$9.4 - $16.7 $14,353 - $25,500
1,527 Added 66.39%
3,827 $58,000
Q3 2020

Nov 12, 2020

BUY
$10.54 - $24.96 $24,241 - $57,408
2,300 New
2,300 $24,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $433M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.